Maltz M B, Davies D W, Lau C P, Creamer J E, Banim S O, Camm A J
Br J Clin Pharmacol. 1986 Oct;22(4):463-7. doi: 10.1111/j.1365-2125.1986.tb02918.x.
The effects of oral nitrendipine and oral propranolol, alone and in combination, on AV conduction have been examined in 11 patients with essential hypertension in whom arterial pressure was not adequately controlled despite treatment with thiazide diuretics. The study was performed double-blind. After a drug free period of 1 week, the patients received two 7 day courses of drug therapy after initial control measurements. Five of the eleven patients were randomised to receive nitrendipine 20 mg daily, the other six patients received propranolol (Inderal LA 160 mg daily) for the first week of therapy. During week 2, 10 patients received combined therapy. In the 10 patients who completed the study, oral nitrendipine, given either alone or in combination with oral propranolol, had no significant effect on resting PR, QRS, QT intervals nor on AV conduction as assessed by ambulatory electrocardiography. Propranolol did not affect the resting PR interval but significantly increased PR intervals on the ambulatory ECG recordings during single and combined therapy. However the maximum PR intervals remained within normal limits.
在11例原发性高血压患者中,研究了口服尼群地平和口服普萘洛尔单独及联合应用对房室传导的影响。这些患者尽管接受了噻嗪类利尿剂治疗,但动脉血压仍未得到充分控制。研究采用双盲法。在1周的无药期后,患者在进行初始对照测量后接受两个为期7天的药物治疗疗程。11例患者中有5例被随机分配接受每日20毫克尼群地平治疗,另外6例患者在治疗的第一周接受普萘洛尔(长效心可定,每日160毫克)治疗。在第2周,10例患者接受联合治疗。在完成研究的10例患者中,口服尼群地平单独或与口服普萘洛尔联合应用时,对静息PR、QRS、QT间期以及动态心电图评估的房室传导均无显著影响。普萘洛尔对静息PR间期无影响,但在单药治疗和联合治疗期间,动态心电图记录显示PR间期显著延长。然而,最大PR间期仍在正常范围内。